These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 30269363)

  • 1. JQ1 and PI3K inhibition synergistically reduce salivary adenoid cystic carcinoma malignancy by targeting the c-Myc and EGFR signaling pathways.
    Liu X; Wu H; Huang P; Zhang F
    J Oral Pathol Med; 2019 Jan; 48(1):43-51. PubMed ID: 30269363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BET bromodomain inhibition of MYC-amplified medulloblastoma.
    Bandopadhayay P; Bergthold G; Nguyen B; Schubert S; Gholamin S; Tang Y; Bolin S; Schumacher SE; Zeid R; Masoud S; Yu F; Vue N; Gibson WJ; Paolella BR; Mitra SS; Cheshier SH; Qi J; Liu KW; Wechsler-Reya R; Weiss WA; Swartling FJ; Kieran MW; Bradner JE; Beroukhim R; Cho YJ
    Clin Cancer Res; 2014 Feb; 20(4):912-25. PubMed ID: 24297863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The BET bromodomain inhibitor, JQ1, facilitates c-FLIP degradation and enhances TRAIL-induced apoptosis independent of BRD4 and c-Myc inhibition.
    Yao W; Yue P; Khuri FR; Sun SY
    Oncotarget; 2015 Oct; 6(33):34669-79. PubMed ID: 26415225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Silencing geranylgeranyltransferase I inhibits the migration and invasion of salivary adenoid cystic carcinoma through RhoA/ROCK1/MLC signaling and suppresses proliferation through cell cycle regulation.
    Chi Z; Wang Q; Tong L; Qiu J; Yang F; Guo Q; Li W; Zheng J; Chen Z
    Cell Biol Int; 2024 Feb; 48(2):174-189. PubMed ID: 37853939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-targeting BET bromodomain BRD4 and RAC1 suppresses growth, stemness and tumorigenesis by disrupting the c-MYC-G9a-FTH1axis and downregulating HDAC1 in molecular subtypes of breast cancer.
    Ali A; Shafarin J; Unnikannan H; Al-Jabi N; Jabal RA; Bajbouj K; Muhammad JS; Hamad M
    Int J Biol Sci; 2021; 17(15):4474-4492. PubMed ID: 34803511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autocrine epiregulin activates EGFR pathway for lung metastasis via EMT in salivary adenoid cystic carcinoma.
    Liu S; Ye D; Xu D; Liao Y; Zhang L; Liu L; Yu W; Wang Y; He Y; Hu J; Guo W; Wang T; Sun B; Song H; Yin H; Liu J; Wu Y; Zhu H; Zhou BP; Deng J; Zhang Z
    Oncotarget; 2016 May; 7(18):25251-63. PubMed ID: 26958807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brd4 Regulates the Homeostasis of CD8
    Peng Z; Zhang Y; Ma X; Zhou M; Wu S; Song Z; Yuan Y; Chen Y; Li Y; Wang G; Huang F; Qiao Y; Xia B; Liu W; Liu J; Zhang X; He X; Pan T; Xu H; Zhang H
    Front Immunol; 2021; 12():728082. PubMed ID: 34512660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The expression of MACC1 and its role in the proliferation and apoptosis of salivary adenoid cystic carcinoma.
    Li H; Liao X; Liu Y; Shen Z; Gan X; Li H; Huang Z
    J Oral Pathol Med; 2015 Nov; 44(10):810-7. PubMed ID: 25640194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of perineural invasion in salivary adenoid cystic carcinoma by circular RNA RNF111.
    Su R; Zhong S; Wang P; Lin Z
    Clin Transl Oncol; 2023 Nov; 25(11):3152-3164. PubMed ID: 37222950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bromodomain and extraterminal inhibition blocks tumor progression and promotes differentiation in neuroblastoma.
    Lee S; Rellinger EJ; Kim KW; Craig BT; Romain CV; Qiao J; Chung DH
    Surgery; 2015 Sep; 158(3):819-26. PubMed ID: 26067464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An epigenetic mechanism of resistance to targeted therapy in T cell acute lymphoblastic leukemia.
    Knoechel B; Roderick JE; Williamson KE; Zhu J; Lohr JG; Cotton MJ; Gillespie SM; Fernandez D; Ku M; Wang H; Piccioni F; Silver SJ; Jain M; Pearson D; Kluk MJ; Ott CJ; Shultz LD; Brehm MA; Greiner DL; Gutierrez A; Stegmaier K; Kung AL; Root DE; Bradner JE; Aster JC; Kelliher MA; Bernstein BE
    Nat Genet; 2014 Apr; 46(4):364-70. PubMed ID: 24584072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BET inhibition as a new strategy for the treatment of gastric cancer.
    Montenegro RC; Clark PG; Howarth A; Wan X; Ceroni A; Siejka P; Nunez-Alonso GA; Monteiro O; Rogers C; Gamble V; Burbano R; Brennan PE; Tallant C; Ebner D; Fedorov O; O'Neill E; Knapp S; Dixon D; Müller S
    Oncotarget; 2016 Jul; 7(28):43997-44012. PubMed ID: 27259267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study on enhanced sensitivity to DNA damage in POLQ knocking-down salivary of adenoid cystic carcinoma-83 cells].
    Bai H; Liu H; Zhu L; Liu C; Xiao J
    Shanghai Kou Qiang Yi Xue; 2023 Apr; 32(2):120-125. PubMed ID: 37153990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of BET Bromodomain Proteins with GS-5829 and GS-626510 in Uterine Serous Carcinoma, a Biologically Aggressive Variant of Endometrial Cancer.
    Bonazzoli E; Predolini F; Cocco E; Bellone S; Altwerger G; Menderes G; Zammataro L; Bianchi A; Pettinella F; Riccio F; Han C; Yadav G; Lopez S; Manzano A; Manara P; Buza N; Hui P; Wong S; Litkouhi B; Ratner E; Silasi DA; Huang GS; Azodi M; Schwartz PE; Schlessinger J; Santin AD
    Clin Cancer Res; 2018 Oct; 24(19):4845-4853. PubMed ID: 29941483
    [No Abstract]   [Full Text] [Related]  

  • 15. Inducible STAT3 NH2 terminal mono-ubiquitination promotes BRD4 complex formation to regulate apoptosis.
    Ray S; Zhao Y; Jamaluddin M; Edeh CB; Lee C; Brasier AR
    Cell Signal; 2014 Jul; 26(7):1445-55. PubMed ID: 24657799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bromodomain and Extraterminal Protein Inhibitor JQ1 Suppresses Thyroid Tumor Growth in a Mouse Model.
    Zhu X; Enomoto K; Zhao L; Zhu YJ; Willingham MC; Meltzer P; Qi J; Cheng SY
    Clin Cancer Res; 2017 Jan; 23(2):430-440. PubMed ID: 27440272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BRD4 as a therapeutic target for atrial fibrosis and atrial fibrillation.
    Song S; Yuan J; Fang G; Li Y; Ding S; Wang Y; Wang Q
    Eur J Pharmacol; 2024 Aug; 977():176714. PubMed ID: 38849043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of BET Bromodomain Inhibitor JQ1 on Double-Expressor Lymphoma Cell Lines and Its Mechanism].
    Chen XY; Yan X; Song BY; Sun J; Mu LJ; Li WP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Aug; 30(4):1094-1100. PubMed ID: 35981367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CBFβ-SMMHC Inhibition Triggers Apoptosis by Disrupting MYC Chromatin Dynamics in Acute Myeloid Leukemia.
    Pulikkan JA; Hegde M; Ahmad HM; Belaghzal H; Illendula A; Yu J; O'Hagan K; Ou J; Muller-Tidow C; Wolfe SA; Zhu LJ; Dekker J; Bushweller JH; Castilla LH
    Cell; 2018 Jun; 174(1):172-186.e21. PubMed ID: 29958106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CCAT1 is an enhancer-templated RNA that predicts BET sensitivity in colorectal cancer.
    McCleland ML; Mesh K; Lorenzana E; Chopra VS; Segal E; Watanabe C; Haley B; Mayba O; Yaylaoglu M; Gnad F; Firestein R
    J Clin Invest; 2016 Feb; 126(2):639-52. PubMed ID: 26752646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.